Literature DB >> 16781920

Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

H Bryant Nguyen1, Emanuel P Rivers, Fredrick M Abrahamian, Gregory J Moran, Edward Abraham, Stephen Trzeciak, David T Huang, Tiffany Osborn, Dennis Stevens, David A Talan.   

Abstract

Severe sepsis and septic shock are as common and lethal as other acute life-threatening conditions that emergency physicians routinely confront such as acute myocardial infarction, stroke, and trauma. Recent studies have led to a better understanding of the pathogenic mechanisms and the development of new or newly applied therapies. These therapies place early and aggressive management of severe sepsis and septic shock as integral to improving outcome. This independent review of the literature examines the recent pathogenic, diagnostic, and therapeutic advances in severe sepsis and septic shock for adults, with particular relevance to emergency practice. Recommendations are provided for therapies that have been shown to improve outcomes, including early goal-directed therapy, early and appropriate antimicrobials, source control, recombinant human activated protein C, corticosteroids, and low tidal volume mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781920     DOI: 10.1016/j.annemergmed.2006.02.015

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  68 in total

1.  Platelet aggregation in severe sepsis.

Authors:  Gábor Woth; Adrienn Varga; Subhamay Ghosh; Miklós Krupp; Tamás Kiss; Lajos Bogár; Diana Mühl
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

2.  Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury.

Authors:  Kathryn A Seely; Joseph H Holthoff; Samuel T Burns; Zhen Wang; Keshari M Thakali; Neriman Gokden; Sung W Rhee; Philip R Mayeux
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

3.  Implementing early goal-directed therapy in the emergency setting: the challenges and experiences of translating research innovations into clinical reality in academic and community settings.

Authors:  Alan E Jones; Nathan I Shapiro; Michael Roshon
Journal:  Acad Emerg Med       Date:  2007-07-13       Impact factor: 3.451

4.  Neutropenic patient with fever and abdominal pain.

Authors:  Hallie Metz; Carrie Tibbles
Journal:  Intern Emerg Med       Date:  2008-03       Impact factor: 3.397

Review 5.  Echocardiography in the intensive care unit: from evolution to revolution?

Authors:  Antoine Vieillard-Baron; Michel Slama; Bernard Cholley; Gérard Janvier; Philippe Vignon
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

6.  Opportunities for Emergency Medical Services care of sepsis.

Authors:  Henry E Wang; Matthew D Weaver; Nathan I Shapiro; Donald M Yealy
Journal:  Resuscitation       Date:  2009-12-16       Impact factor: 5.262

7.  Implementation of an evidence-based sepsis program in the intensive care unit: evident or not?

Authors:  Dominique M Vandijck; Stijn I Blot; Dirk P Vogelaers
Journal:  Crit Care       Date:  2009-10-07       Impact factor: 9.097

8.  Role of Caveolin Proteins in Sepsis.

Authors:  Grzegorz Sowa
Journal:  Pediatr Ther       Date:  2012-01-12

9.  Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner.

Authors:  Anje Cauwels; Emmanuel S Buys; Robrecht Thoonen; Lisa Geary; Joris Delanghe; Sruti Shiva; Peter Brouckaert
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

10.  Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort.

Authors:  Juan Gálvez-Acebal; Jesús Rodríguez-Baño; Francisco J Martínez-Marcos; Jose M Reguera; Antonio Plata; Josefa Ruiz; Manuel Marquez; Jose M Lomas; Javier de la Torre-Lima; Carmen Hidalgo-Tenorio; Arístides de Alarcón
Journal:  BMC Infect Dis       Date:  2010-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.